Galderma

Galderma S.A.
Company type	Public
Traded as	SIX: GALD
Industry	Dermatology; Pharmaceuticals;
Founded	In 1961 in Texas
Headquarters	Zug, Switzerland
Key people	Flemming Ørnskov (CEO); Thomas Ebeling (chairman);
Revenue	US$4.08 billion (2023)
Owner	Consortium led by EQT AB (2019–2024); Nestle (1981–2019); L'Oréal (1981–2014);
Number of employees	6,500 (2024)
Website	galderma.com

Galderma SA is an American-Swiss pharmaceutical company specializing in dermatological treatments and skin care products. Formerly a subsidiary of L'Oréal and Nestlé, it was acquired by a consortium of private institutional investors in 2019 and remained under their ownership until its IPO in 2024.

Galderma was formed in 1981 as a joint venture between Nestlé and L'Oréal, and later became a wholly owned subsidiary of Nestlé. Since 2019, it has belonged to an investment consortium. The company, headed by president and CEO Flemming Ørnskov (ex-Shire), has 33 sites in 100 countries with a worldwide network of distributors and employs more than 4,600 people. The headquarters is based in Zug, Switzerland.